Patrys (PAB.AX) Stock Price

Patrys Price

ASX·CLOSED
0.04AUD+0.00 (+0.00 %)
Market closed

Revenue has compounded at 15.7% per year over the past 18 years to 828,500.00 AUD. Patrys's net margin stands at -363.7%, down from -303.6% several years earlier. The stock trades about 60% above its 52-week low.

Patrys stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Patrys over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Patrys stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Patrys's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Patrys Stock Price History
DatePatrys Price
7/10/20260.04 AUD
7/9/20260.04 AUD
7/8/20260.04 AUD
7/7/20260.04 AUD
7/6/20260.04 AUD
7/3/20260.04 AUD
7/2/20260.04 AUD
7/1/20260.04 AUD
6/30/20260.04 AUD
6/29/20260.04 AUD
6/26/20260.04 AUD
6/25/20260.04 AUD
6/24/20260.04 AUD
6/23/20260.04 AUD
6/22/20260.05 AUD
6/19/20260.05 AUD
6/18/20260.05 AUD
6/17/20260.05 AUD
6/16/20260.05 AUD
6/15/20260.05 AUD
6/12/20260.04 AUD
6/11/20260.04 AUD
6/10/20260.04 AUD
6/9/20260.04 AUD
6/5/20260.04 AUD
6/4/20260.04 AUD
6/3/20260.04 AUD
6/2/20260.05 AUD
6/1/20260.05 AUD
5/29/20260.05 AUD
5/28/20260.04 AUD
5/27/20260.04 AUD
5/26/20260.04 AUD
5/25/20260.04 AUD
5/22/20260.04 AUD
5/21/20260.04 AUD
5/20/20260.03 AUD
5/19/20260.03 AUD
5/18/20260.03 AUD
5/15/20260.03 AUD
5/14/20260.03 AUD
5/13/20260.03 AUD
5/12/20260.03 AUD
5/11/20260.03 AUD
5/8/20260.03 AUD
5/7/20260.03 AUD
5/6/20260.03 AUD
5/5/20260.03 AUD
5/4/20260.03 AUD
5/1/20260.03 AUD
4/30/20260.03 AUD
4/29/20260.03 AUD
4/28/20260.03 AUD
4/27/20260.03 AUD
4/24/20260.03 AUD
4/23/20260.03 AUD
4/22/20260.03 AUD
4/21/20260.03 AUD
4/20/20260.03 AUD
4/15/20260.03 AUD
4/14/20260.03 AUD
4/13/20260.03 AUD
4/9/20260.03 AUD
4/8/20260.03 AUD
4/7/20260.03 AUD
4/2/20260.03 AUD
4/1/20260.03 AUD
3/31/20260.03 AUD
3/30/20260.03 AUD
3/27/20260.03 AUD
3/26/20260.03 AUD
3/25/20260.03 AUD
3/23/20260.03 AUD
3/20/20260.03 AUD
3/19/20260.03 AUD
3/18/20260.03 AUD
3/17/20260.03 AUD
3/16/20260.03 AUD
3/13/20260.03 AUD
3/12/20260.03 AUD
3/11/20260.03 AUD
3/10/20260.03 AUD
3/9/20260.03 AUD
3/6/20260.04 AUD
3/5/20260.04 AUD
3/4/20260.04 AUD
3/3/20260.04 AUD
3/2/20260.04 AUD
2/27/20260.04 AUD
2/26/20260.04 AUD
2/25/20260.04 AUD
2/24/20260.04 AUD
2/23/20260.03 AUD
2/20/20260.04 AUD
2/19/20260.03 AUD
2/18/20260.03 AUD
2/17/20260.03 AUD
2/16/20260.03 AUD
2/13/20260.04 AUD
2/12/20260.04 AUD
2/11/20260.04 AUD
2/10/20260.04 AUD
2/9/20260.03 AUD
2/6/20260.03 AUD
2/5/20260.04 AUD
2/4/20260.04 AUD
2/3/20260.04 AUD
2/2/20260.03 AUD
1/30/20260.03 AUD
1/29/20260.03 AUD
1/28/20260.03 AUD
1/27/20260.03 AUD
1/23/20260.03 AUD
1/22/20260.03 AUD
1/21/20260.03 AUD
1/20/20260.03 AUD
1/19/20260.03 AUD
1/16/20260.03 AUD
1/15/20260.03 AUD
1/14/20260.03 AUD
1/13/20260.03 AUD
1/12/20260.03 AUD
1/9/20260.03 AUD
1/8/20260.03 AUD
1/7/20260.03 AUD
1/6/20260.03 AUD
1/5/20260.03 AUD
12/31/20250.03 AUD
12/29/20250.03 AUD
12/24/20250.03 AUD
12/22/20250.03 AUD
12/19/20250.03 AUD
12/18/20250.03 AUD
12/17/20250.03 AUD
12/16/20250.03 AUD
12/15/20250.03 AUD
12/12/20250.03 AUD
12/11/20250.03 AUD
12/10/20250.03 AUD
12/9/20250.03 AUD
12/8/20250.03 AUD
12/5/20250.03 AUD
12/4/20250.03 AUD
12/3/20250.03 AUD
12/2/20250.04 AUD
12/1/20250.04 AUD
11/28/20250.03 AUD
11/27/20250.03 AUD
11/26/20250.03 AUD
11/21/20250.04 AUD
11/20/20250.04 AUD
11/19/20250.04 AUD
11/18/20250.04 AUD
11/17/20250.04 AUD
11/14/20250.04 AUD
11/13/20250.04 AUD
11/12/20250.04 AUD
11/11/20250.04 AUD
11/10/20250.04 AUD
11/7/20250.04 AUD
11/6/20250.04 AUD
11/5/20250.04 AUD
11/4/20250.04 AUD
11/3/20250.04 AUD
10/31/20250.04 AUD
10/30/20250.04 AUD
10/29/20250.04 AUD
10/28/20250.04 AUD
10/27/20250.05 AUD
10/24/20250.04 AUD
Access this data via the Eulerpool API
Get Free API Key

Patrys Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
520,500.00 AUD
-2.50 M AUD
-2.50 M AUD
Jan 1, 2019
844,400.00 AUD
-3.41 M AUD
-411,300.00 AUD
Jan 1, 2020
772,800.00 AUD
-2.75 M AUD
-2.75 M AUD
Jan 1, 2021
1.34 M AUD
-4.06 M AUD
-4.06 M AUD
Jan 1, 2022
3.33 M AUD
-6.78 M AUD
-6.78 M AUD
Jan 1, 2023
2.85 M AUD
-7.06 M AUD
-7.06 M AUD
Jan 1, 2024
1.39 M AUD
-3.54 M AUD
-3.54 M AUD
Jan 1, 2025
828,500.00 AUD
-2.71 M AUD
-3.01 M AUD

Patrys Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 12, 2026, 9:55 AM
 
REVENUEM AUD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM AUD
NET INCOMEM AUD
NET INCOME GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
–1.001.00––––––––1.003.002.001.00–
––––––––––––200.00-33.33-50.00–
–200.00200.00––––––––100.00100.00100.00200.00–
2.002.002.002.002.002.002.002.002.002.002.001.003.002.002.002.00
-7.00-7.00-5.00-3.00-7.00-8.00-1.00-1.00-2.00–-2.00-4.00-6.00-7.00-3.00-3.00
-12.50–-28.57-40.00133.3314.29-87.50–100.00––100.0050.0016.67-57.14–
19.2723.2332.0251.7759.1668.1269.8573.3289.40101.67101.75151.87184.17193.08193.11194.14
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Patrys generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Patrys retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Patrys's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Patrys has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Patrys's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Patrys stock margins

The Patrys margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Patrys. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Patrys.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
99.93 %
-479.79 %
-479.79 %
Jan 1, 2019
99.93 %
-403.99 %
-48.71 %
Jan 1, 2020
99.93 %
-355.65 %
-355.65 %
Jan 1, 2021
100.12 %
-303.56 %
-303.56 %
Jan 1, 2022
99.89 %
-203.40 %
-203.40 %
Jan 1, 2023
99.93 %
-247.61 %
-247.61 %
Jan 1, 2024
99.93 %
-253.85 %
-253.85 %
Jan 1, 2025
99.93 %
-327.05 %
-363.71 %

Patrys Stock Revenue, EBIT, Earnings per Share

The Patrys earnings per share therefore indicates how much revenue Patrys has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.09 AUD
-0.42 AUD
-0.42 AUD
Jan 1, 2019
0.12 AUD
-0.50 AUD
-0.06 AUD
Jan 1, 2020
0.11 AUD
-0.41 AUD
-0.41 AUD
Jan 1, 2021
0.13 AUD
-0.40 AUD
-0.40 AUD
Jan 1, 2022
0.27 AUD
-0.55 AUD
-0.55 AUD
Jan 1, 2023
0.22 AUD
-0.55 AUD
-0.55 AUD
Jan 1, 2024
0.11 AUD
-0.27 AUD
-0.27 AUD
Jan 1, 2025
0.06 AUD
-0.21 AUD
-0.23 AUD

Patrys business model & stock analysis

The company Patrys Ltd is a biotechnology company based in Perth, Australia. It was founded in 2001 by a team of scientists and investors with the aim of developing and marketing targeted cancer treatments. Patrys focuses on the development of monoclonal antibodies and peptides containing therapeutic agents for cancer treatment. The main business model of Patrys is to develop and market new treatment options for cancer patients. The company utilizes the latest advancements in cancer research to develop innovative therapies tailored to the specific characteristics of each type of cancer. Patrys collaborates with leading scientists, research organizations, and pharmaceutical companies to develop a comprehensive portfolio of cancer treatments. Patrys has different business areas, all focused on the development of cancer treatments. One of these areas is the field of monoclonal antibodies, where Patrys concentrates on developing antibodies that can recognize and target specific proteins in cancer tissue. Another area focuses on the development of peptides specifically tailored to cancer cells. Patrys' products cover a variety of cancer types, including lung cancer, breast cancer, prostate cancer, colorectal cancer, and leukemia. The company's leading product is currently the antibody therapeutic PAT-LM1, used for the treatment of lung cancer. PAT-LM1 is a monoclonal antibody that targets a specific protein in the tumor, effectively combating the disease. The drug is currently in phase II clinical trials and showing promising results. Patrys is a company operating in a growing market. The global demand for cancer treatments is increasing, and Patrys has established itself as a significant player in this field. The company has gained recognition in recent years for its innovative therapy approaches and strong research and development team. Patrys aims to provide cancer patients with real hope for a cure and improve their quality of life. Overall, Patrys is a company operating in a rapidly growing market with a promising future. The company has developed a wide range of cancer treatments and works closely with leading experts and pharmaceutical companies to strengthen its position as an innovative and relevant player in cancer research. Patrys has a clear vision that it pursues, presenting an opportunity to play a significant role in the near future in a rapidly growing and highly relevant market.

Patrys SWOT Analysis

Strengths

Patrys Ltd possesses several strengths that contribute to its success:

  • Strong brand reputation and recognition
  • Highly skilled and experienced workforce
  • Diversified product portfolio
  • Efficient supply chain management
  • Effective marketing and promotional strategies

Weaknesses

Despite its strengths, Patrys Ltd also faces certain weaknesses that need to be addressed:

  • Limited market presence in certain regions
  • Relatively higher production costs compared to competitors
  • Dependence on a few key suppliers
  • Slow adoption of new technologies
  • Inefficient internal communication processes

Opportunities

Patrys Ltd can capitalize on the following opportunities to further enhance its growth:

  • Expanding into emerging markets with high demand
  • Introduction of innovative products or services
  • Partnerships or collaborations with complementary businesses
  • Increasing consumer awareness and demand for sustainable products
  • Growing e-commerce market and online sales potential

Threats

Patrys Ltd should be cautious about the following threats that may impact its business:

  • Intense competition within the industry
  • Changes in government regulations or policies
  • Economic downturn or recession
  • Rapidly evolving market trends and consumer preferences
  • Potential supply chain disruptions

Patrys Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Patrys historical P/E ratio, EBIT multiple, and P/S ratio

Patrys annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Patrys shares outstanding

The number of shares of Patrys was 12.94 M in 2025. This indicates how many shares Patrys is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
5.96 M Stocks
Jan 1, 2019
6.78 M Stocks
Jan 1, 2020
6.78 M Stocks
Jan 1, 2021
10.12 M Stocks
Jan 1, 2022
12.28 M Stocks
Jan 1, 2023
12.87 M Stocks
Jan 1, 2024
12.87 M Stocks
Jan 1, 2025
12.94 M Stocks

Patrys stock splits

In Patrys's history, there have been no stock splits.
Price targets and forecasts for Patrys are not yet available.

Patrys shareholder structure

% Name
18.86721%
Kite (Leanne)
Kite (Leanne)
11.04027%
Cercarelli (Dino)
Cercarelli (Dino)
10.30176%
Uvarov (Anton)
Uvarov (Anton)
6.66891%
Campbell (James)
Campbell (James)
4.59555%
Marusic (Mladen)
Marusic (Mladen)
4.49629%
Warragoon Investments Pty. Ltd
Warragoon Investments Pty. Ltd

Patrys Executives and Management Board

JC

Dr. James Campbell

Chief Executive Officer, Managing Director, Executive Director · since 2014

Compensation718,035.00 AUD
DG

Dr. Deanne Greenwood

Vice President - Business Development & Intellectual Property

Compensation146,291.00 AUD
MS

Mr. Michael Stork

Non-Executive Deputy Chairman of the Board · since 2007

Compensation5,002.00 AUD
CG

Dr. Charmaine Gittleson

Chairman of the Board · since 2022

VD

Ms. Valentina Dubljevic

Vice President - Research and Development

Frequently asked questions about Patrys

The main competitors of Patrys Ltd in the market include other companies operating in the biotechnology and pharmaceutical industries. These competitors may include well-established firms with a similar focus on developing innovative therapies and drugs. However, it is essential to conduct thorough market research to determine the specific competitors relevant to Patrys Ltd's offerings and target market. Stay updated with Patrys Ltd's latest announcements and industry news to gather accurate information about its current competitors.

All fundamentals and in-depth analysis of Patrys

Our stock analysis for Patrys stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Patrys. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Patrys Stock
Patrys Revenue→
Patrys Stock
Patrys Net Income→
Patrys Stock
Patrys P/E→
Patrys Stock
Patrys P/S→
Patrys Stock
Patrys EBIT→
Patrys Stock
Patrys Dividend→
Patrys Stock
Patrys Directors Dealings→
Patrys Stock
Patrys Stocks→
Patrys Stock
Patrys Market capitalization→
Patrys Stock
Patrys Debt→
Patrys Stock
Patrys Liabilities→
Patrys Stock
Patrys Equity→
Patrys Stock
Patrys AAQS→
Patrys Stock
Patrys Employees→
Patrys Stock
Patrys ROE→
Patrys Stock
Patrys ROA→
Patrys Stock
Patrys ROCE→
Patrys Stock
Patrys News→
Patrys Stock
Patrys Analyst Price Targets→

Health Stocks

Paul HartmannPatrangsit Healthcare Group PCLPAVmedPathfinder Cell TherapyPaxman AB (publ)Passage BioPCLPasithea TherapeuticsPDS BiotechnologyParnax LabPeak ProcessingPark Dental PartnersAll Stocks A–Z →